UniProt ID | STAT3_MOUSE | |
---|---|---|
UniProt AC | P42227 | |
Protein Name | Signal transducer and activator of transcription 3 | |
Gene Name | Stat3 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 770 | |
Subcellular Localization | Cytoplasm. Nucleus. Predominantly present in the cytoplasm without stimuli. Upon leukemia inhibitory factor (LIF) stimulation, accumulates in the nucleus. The complex composed of BART and ARL2 plays an important role in the nuclear translocation and | |
Protein Description | Signal transducer and transcription activator that mediates cellular responses to interleukins, KITLG/SCF, LEP and other growth factors. Once activated, recruits coactivators, such as NCOA1 or MED1, to the promoter region of the target gene. May mediate cellular responses to activated FGFR1, FGFR2, FGFR3 and FGFR4. Binds to the interleukin-6 (IL-6)-responsive elements identified in the promoters of various acute-phase protein genes. Activated by IL31 through IL31RA. Acts as a regulator of inflammatory response by regulating differentiation of naive CD4(+) T-cells into T-helper Th17 or regulatory T-cells (Treg): deacetylation and oxidation of lysine residues by LOXL3, leads to disrupt STAT3 dimerization and inhibit its transcription activity (By similarity). Involved in cell cycle regulation by inducing the expression of key genes for the progression from G1 to S phase, such as CCND1 (By similarity). Mediates the effects of LEP on melanocortin production, body energy homeostasis and lactation. [PubMed: 12594516 May play an apoptotic role by transctivating BIRC5 expression under LEP activation] | |
Protein Sequence | MAQWNQLQQLDTRYLEQLHQLYSDSFPMELRQFLAPWIESQDWAYAASKESHATLVFHNLLGEIDQQYSRFLQESNVLYQHNLRRIKQFLQSRYLEKPMEIARIVARCLWEESRLLQTAATAAQQGGQANHPTAAVVTEKQQMLEQHLQDVRKRVQDLEQKMKVVENLQDDFDFNYKTLKSQGDMQDLNGNNQSVTRQKMQQLEQMLTALDQMRRSIVSELAGLLSAMEYVQKTLTDEELADWKRRQQIACIGGPPNICLDRLENWITSLAESQLQTRQQIKKLEELQQKVSYKGDPIVQHRPMLEERIVELFRNLMKSAFVVERQPCMPMHPDRPLVIKTGVQFTTKVRLLVKFPELNYQLKIKVCIDKDSGDVAALRGSRKFNILGTNTKVMNMEESNNGSLSAEFKHLTLREQRCGNGGRANCDASLIVTEELHLITFETEVYHQGLKIDLETHSLPVVVISNICQMPNAWASILWYNMLTNNPKNVNFFTKPPIGTWDQVAEVLSWQFSSTTKRGLSIEQLTTLAEKLLGPGVNYSGCQITWAKFCKENMAGKGFSFWVWLDNIIDLVKKYILALWNEGYIMGFISKERERAILSTKPPGTFLLRFSESSKEGGVTFTWVEKDISGKTQIQSVEPYTKQQLNNMSFAEIIMGYKIMDATNILVSPLVYLYPDIPKEEAFGKYCRPESQEHPEADPGSAAPYLKTKFICVTPTTCSNTIDLPMSPRTLDSLMQFGNNGEGAEPSAGGQFESLTFDMDLTSECATSPM | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAQWNQLQQ ------CCCHHHHHH | 24.09 | - | |
31 | Methylation | DSFPMELRQFLAPWI CCCCHHHHHHHHHHH | 16.34 | 30686609 | |
45 | Phosphorylation | IESQDWAYAASKESH HHCCCHHHHHCHHHC | 9.84 | 22817900 | |
49 | Acetylation | DWAYAASKESHATLV CHHHHHCHHHCHHHH | 59.52 | 67919 | |
49 | Ubiquitination | DWAYAASKESHATLV CHHHHHCHHHCHHHH | 59.52 | - | |
79 | Phosphorylation | LQESNVLYQHNLRRI HHHHCHHHHHHHHHH | 11.93 | 29514104 | |
87 | Acetylation | QHNLRRIKQFLQSRY HHHHHHHHHHHHHCC | 32.93 | 67925 | |
87 | Ubiquitination | QHNLRRIKQFLQSRY HHHHHHHHHHHHHCC | 32.93 | 22790023 | |
177 | Ubiquitination | DDFDFNYKTLKSQGD HHCCCCHHHHHCCCC | 48.78 | 22790023 | |
180 | Ubiquitination | DFNYKTLKSQGDMQD CCCHHHHHCCCCCCC | 46.06 | 22790023 | |
244 | Ubiquitination | DEELADWKRRQQIAC HHHHHHHHHHHCCEE | 37.95 | 22790023 | |
294 | Ubiquitination | LQQKVSYKGDPIVQH HHHHHHCCCCCHHHC | 49.70 | - | |
294 | Malonylation | LQQKVSYKGDPIVQH HHHHHHCCCCCHHHC | 49.70 | 26320211 | |
318 | Ubiquitination | ELFRNLMKSAFVVER HHHHHHHHHCCEEEC | 41.62 | 22790023 | |
363 | Ubiquitination | PELNYQLKIKVCIDK HHHCCEEEEEEEEEC | 25.59 | 22790023 | |
370 | Acetylation | KIKVCIDKDSGDVAA EEEEEEECCCCCEEH | 33.60 | 22826441 | |
381 | Phosphorylation | DVAALRGSRKFNILG CEEHHCCCCCEEEEC | 26.34 | 25338131 | |
539 | Phosphorylation | LLGPGVNYSGCQITW HHCCCCCCCCCEEEE | 12.20 | 29514104 | |
601 | Deamination | ERAILSTKPPGTFLL HHHHHCCCCCCEEEE | 45.93 | - | |
601 | Acetylation | ERAILSTKPPGTFLL HHHHHCCCCCCEEEE | 45.93 | - | |
615 | Deamination | LRFSESSKEGGVTFT EEEECCCCCCCEEEE | 70.43 | - | |
615 | Acetylation | LRFSESSKEGGVTFT EEEECCCCCCCEEEE | 70.43 | - | |
626 | Ubiquitination | VTFTWVEKDISGKTQ EEEEEEEECCCCCEE | 51.23 | 22790023 | |
631 | Deamination | VEKDISGKTQIQSVE EEECCCCCEEEEECC | 30.39 | - | |
631 | Acetylation | VEKDISGKTQIQSVE EEECCCCCEEEEECC | 30.39 | 23806337 | |
631 | Ubiquitination | VEKDISGKTQIQSVE EEECCCCCEEEEECC | 30.39 | 22790023 | |
679 | Acetylation | YLYPDIPKEEAFGKY HHCCCCCHHHHCCCC | 69.40 | 1921455 | |
685 | Deamination | PKEEAFGKYCRPESQ CHHHHCCCCCCHHHC | 34.42 | - | |
685 | Acetylation | PKEEAFGKYCRPESQ CHHHHCCCCCCHHHC | 34.42 | 60013 | |
691 | Phosphorylation | GKYCRPESQEHPEAD CCCCCHHHCCCCCCC | 43.48 | 25619855 | |
701 | Phosphorylation | HPEADPGSAAPYLKT CCCCCCCCCCCCCCE | 27.01 | 25619855 | |
704 (in isoform 3) | Phosphorylation | - | 34.40 | 22499769 | |
705 | Phosphorylation | DPGSAAPYLKTKFIC CCCCCCCCCCEEEEE | 18.99 | 17283176 | |
707 | Ubiquitination | GSAAPYLKTKFICVT CCCCCCCCEEEEEEC | 43.77 | 22790023 | |
707 | Acetylation | GSAAPYLKTKFICVT CCCCCCCCEEEEEEC | 43.77 | 1921459 | |
708 | Phosphorylation | SAAPYLKTKFICVTP CCCCCCCEEEEEECC | 28.70 | 25777480 | |
709 | Acetylation | AAPYLKTKFICVTPT CCCCCCEEEEEECCC | 31.01 | 14881003 | |
713 (in isoform 3) | Phosphorylation | - | 6.50 | 29514104 | |
714 | Phosphorylation | KTKFICVTPTTCSNT CEEEEEECCCCCCCC | 15.54 | 21082442 | |
715 (in isoform 3) | Phosphorylation | - | 12.81 | 25266776 | |
716 | Phosphorylation | KFICVTPTTCSNTID EEEEECCCCCCCCCC | 30.94 | 25619855 | |
717 | Phosphorylation | FICVTPTTCSNTIDL EEEECCCCCCCCCCC | 18.36 | 25619855 | |
717 | O-linked_Glycosylation | FICVTPTTCSNTIDL EEEECCCCCCCCCCC | 18.36 | 26866564 | |
719 | Phosphorylation | CVTPTTCSNTIDLPM EECCCCCCCCCCCCC | 34.61 | 25619855 | |
719 | O-linked_Glycosylation | CVTPTTCSNTIDLPM EECCCCCCCCCCCCC | 34.61 | 26866564 | |
721 | Phosphorylation | TPTTCSNTIDLPMSP CCCCCCCCCCCCCCH | 10.28 | 22942356 | |
727 | Phosphorylation | NTIDLPMSPRTLDSL CCCCCCCCHHHHHHH | 14.86 | 27087446 | |
754 | Phosphorylation | SAGGQFESLTFDMDL CCCCCEEEEEEEEEC | 33.72 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
705 | Y | Phosphorylation | Kinase | CDK8 | Q8R3L8 | PSP |
705 | Y | Phosphorylation | Kinase | SRC | P05480 | PSP |
705 | Y | Phosphorylation | Kinase | PTK6 | Q64434 | Uniprot |
705 | Y | Phosphorylation | Kinase | EPHB1 | P54762 | PSP |
705 | Y | Phosphorylation | Kinase | FER | P70451 | Uniprot |
705 | Y | Phosphorylation | Kinase | JAK1 | P23458 | PSP |
705 | Y | Phosphorylation | Kinase | JAK2 | Q62120 | PSP |
705 | Y | Phosphorylation | Kinase | ALK | Q9UM73 | PSP |
727 | S | Phosphorylation | Kinase | PKCE | P16054 | PSP |
727 | S | Phosphorylation | Kinase | DYRK-FAMILY | - | GPS |
727 | S | Phosphorylation | Kinase | TBK1 | Q9WUN2 | PSP |
727 | S | Phosphorylation | Kinase | NLK | O54949 | Uniprot |
727 | S | Phosphorylation | Kinase | NLK | Q9UBE8 | PSP |
727 | S | Phosphorylation | Kinase | NEK6 | Q9ES70 | Uniprot |
727 | S | Phosphorylation | Kinase | MTOR | Q9JLN9 | PSP |
727 | S | Phosphorylation | Kinase | MAPK14 | P47811 | GPS |
727 | S | Phosphorylation | Kinase | MAPK8 | Q91Y86 | GPS |
727 | S | Phosphorylation | Kinase | MAP3K1 | P53349 | GPS |
727 | S | Phosphorylation | Kinase | MSK1 | Q8C050 | PSP |
727 | S | Phosphorylation | Kinase | PRKCD | P28867 | GPS |
727 | S | Phosphorylation | Kinase | IRAK1 | Q62406 | Uniprot |
727 | S | Phosphorylation | Kinase | HIPK2 | Q9QZR5 | GPS |
727 | S | Phosphorylation | Kinase | DYRK2 | Q5U4C9 | Uniprot |
727 | S | Phosphorylation | Kinase | DAPK3 | O54784 | Uniprot |
727 | S | Phosphorylation | Kinase | CDK8 | P49336 | PSP |
727 | S | Phosphorylation | Kinase | CDK5 | P49615 | PSP |
754 | S | Phosphorylation | Kinase | TBK1 | Q9UHD2 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | Hectd3 | Q3U487 | PMID:30741923 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
727 | S | Phosphorylation |
| 7543024 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of STAT3_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
STAT3_MOUSE | Stat3 | physical | 20211142 | |
PCBP1_MOUSE | Pcbp1 | physical | 17383969 | |
PCBP1_MOUSE | Pcbp1 | genetic | 17383969 | |
IRAK1_MOUSE | Irak1 | physical | 15465816 | |
STAT3_MOUSE | Stat3 | physical | 11579100 | |
FER_MOUSE | Fert2 | physical | 12738762 | |
HES1_MOUSE | Hes1 | physical | 15156153 | |
CYLD_MOUSE | Cyld | physical | 23825949 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale identification and evolution indexing of tyrosinephosphorylation sites from murine brain."; Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.; J. Proteome Res. 7:311-318(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-705, AND MASSSPECTROMETRY. | |
"Identification of tyrosine residues in constitutively activatedfibroblast growth factor receptor 3 involved in mitogenesis, Statactivation, and phosphatidylinositol 3-kinase activation."; Hart K.C., Robertson S.C., Donoghue D.J.; Mol. Biol. Cell 12:931-942(2001). Cited for: FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT TYR-705. | |
"MSK1 and JNKs mediate phosphorylation of STAT3 in UVA-irradiatedmouse epidermal JB6 cells."; Zhang Y., Liu G., Dong Z.; J. Biol. Chem. 276:42534-42542(2001). Cited for: PHOSPHORYLATION AT TYR-705 AND SER-727. |